360 High-Risk Vulnerability Immunization Tool V2.0 vs Cybereason Next-Generation AntiVirus: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Cybereason Next-Generation AntiVirus: NGAV with 9 prevention layers for malware, ransomware & exploit protection. built by Cybereason. Core capabilities include Nine-layer prevention architecture, Endpoint controls for USB and network connections, Traditional and AI-based antivirus engines..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Cybereason Next-Generation AntiVirus differentiates with Nine-layer prevention architecture, Endpoint controls for USB and network connections, Traditional and AI-based antivirus engines.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Cybereason Next-Generation AntiVirus is developed by Cybereason. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Cybereason Next-Generation AntiVirus serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Zero Day. Review the feature comparison above to determine which fits your requirements.